Spots Global Cancer Trial Database for figo stage iii or iv eoc
Every month we try and update this database with for figo stage iii or iv eoc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy | NCT01685255 | Ovarian Cancer Genitourinary (... | Epacadostat tamoxifen | 18 Years - | Incyte Corporation | |
A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy | NCT01685255 | Ovarian Cancer Genitourinary (... | Epacadostat tamoxifen | 18 Years - | Incyte Corporation |